About the Conference

Jointly organised by Precision Health Research, Singapore (PRECISE) and the International Health Cohorts Consortium (IHCC), the conference will bring together some 600 thought leaders, clinicians, scientists, biotechs, and patient advocacy associations from across the world who are at the forefront of precision medicine and public health innovation.

Themed “From Cohorts to Clinics: The New Landscape of Global Healthcare”, the conference seeks to address the challenges and opportunities in translating advances in precision medicine into tangible enhancements in patient care and reshape the landscape of modern healthcare. It also aims to catalyse and promote cross-population cohort research and design cross-cohort pilot projects to address various global challenges.

The three-day conference will be held on-site from 21 to 23 August 2024 in Singapore.

Conference Aims

Through this conference we aim to:

Aim #1 Encourage Scientific Exchange: Thought leaders, policymakers, researchers, and industry stakeholders in the field of precision medicine will have a platform to share their insights, discoveries and findings, facilitating cross-pollination of ideas and methodologies.

Aim #2 Translate Precision Science to Impact Patients: Provide a unique opportunity to bring together the scientific community, clinicians, patients and other stakeholders to integrate scientific advances into patient care, reshaping the landscape of modern healthcare.

Aim #3 Showcase Global Advancements in Genomic and Precision Medicine: Showcase cutting-edge, cost-effective, and clinically effective healthcare solutions and demonstrate a collective dedication to making these advancements accessible, equitable, and beneficial across different populations worldwide.

Aim #4 Bring Diverse Perspectives on Global Challenges: Bring together esteemed speakers from global precision medicine programs across the globe, to provide diverse insights into the latest developments in this rapidly evolving field.

Aim #5 Champion Early-Career Scientists in Genomic and Precision Medicine: Provide emerging researchers with opportunities to showcase their work, gain invaluable insights from the frontiers of genomic research and precision medicine, and engage with leading professionals.

Aim #6 Enhance Cohort Studies and Biobank Integration for Translational Impact: Spotlight the critical role of extensive cohorts and biobanks in advancing genomic and precision medicine to ensure that innovations reach the bedside with ethical integrity and global inclusivity.

About PRECISE

Precision Health Research, Singapore (PRECISE) is the central entity set up to coordinate a whole of government effort to implement Phase II of Singapore’s three-phase National Precision Medicine (NPM) programme.

It aims to transform healthcare in Singapore and improve patient outcomes through new insights into the Asian genome and data-driven healthcare solutions. NPM Phase II will also enhance the breadth and depth of the Precision Medicine-related industry by attracting and anchoring overseas companies in Singapore, while yielding new opportunities for home-grown companies.

PRECISE is a programme under the Consortium for Clinical Research and Innovation, Singapore (CRIS).

For more information, visit www.npm.sg

About IHCC

The International Health Cohorts Consortium (IHCC) aims to create a global platform for translational research – cohort to bedside and cohort to bench – informing the biological and genetic basis for disease and improving clinical care and population health.

It brings large cohorts together to encourage data sharing, improve effciencies and maximise benefits in addressing scientific questions none could answer alone. To address the value and challenges of combining large cohort data across borders, the IHCC has formed two working groups:

Scientific Strategy and Cohorts Enhancement; and
Data Standards and Infrastructure.

For more information, please visit https://ihccglobal.org